Healthy Living/WellnessFDA approves hay fever drug Oralair: Goodbye sneezing and allergy shots. French company Stallergenes' Oralair will soon be available in the U.S. providing new option to patients with hay fever.by Rhodi Lee
Healthy Living/WellnessFDA advisers give thumbs up to MannKind's inhaled insulin drug for diabeticsby Maryanne Moll
TechNew headband device promises an opportunity to stem painful migraines before they hit full forceby Judy Mottl
Healthy Living/WellnessFDA approves hemophilia B drug Alprolix for children and adultsby Lori Sandoval
Healthy Living/WellnessFDA recommends Cologuard stool-based DNA test for colon cancer after it demonstrates 93.3 pct sensitivtyby Rhodi Lee
Healthy Living/WellnessPlaytex issues recall on breast pump power adapters for potential electric shock riskby Rhodi Lee
Healthy Living/WellnessFDA approves HPV test to replace pap smear for cervical cancer detectionby Rhodilee Jean Dolor
Healthy Living/WellnessFDA requests investigation of cholesterol drug's neurocognitive risksby Tabitha Laffernis
Healthy Living/WellnessTestosterone replacement drug Aveed gets the FDA's stamp of approvalby Tabitha Laffernis